Log In
BCIQ
Print this Print this
 

teprenone (geranylgeranylacetone, Selbex), (5E,9E,13E)-6,10,14,18-tetramethylnonadeca-5,9,13,17-tetraen-2-one

  Manage Alerts
Collapse Summary General Information
Company Eisai Co. Ltd.
DescriptionAcyclic polyisoprenoid used for the treatment of gastric ulcers
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationGastric ulcers
Indication DetailsTreat gastric ulcers
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$37.7M

$37.7M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/15/2015

$37.7M

$37.7M

0

Get a free BioCentury trial today